Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus  by Rogove, A.D. & Tsirka, S.E.
Neurotoxic responses by microglia elicited by excitotoxic injury
in the mouse hippocampus
A.D. Rogove* and S.E. Tsirka†
Background: Injury to the brain induces dramatic local changes in gene
expression, cellular morphology and behavior. Activation of microglial cells
occurs as an early event after central nervous system (CNS) injury, but it has
not been determined whether such activation plays a causal role in neuronal
death. We have investigated this question using an excitotoxin-mediated brain
injury model system, in conjunction with an endogenous peptide factor
(macrophage/microglial inhibiting factor, MIF) that ablates microglial
contribution to the cascade. 
Results: Using MIF, we inhibited the microglial activation that normally follows
excitotoxic injury. In cell culture studies, we found that such inhibition blocked
the rapid release of microglia-derived tissue plasminogen activator (tPA), an
extracellular serine protease made by both neurons and microglia, which we
had previously identified as mediating a critical step in excitotoxin-induced
neuronal death. Finally, infusion of MIF into the mouse brain prior to excitotoxic
insult resulted in the protection of neurons from cell death.
Conclusions: Our results demonstrate that microglia undertake a neurotoxic
role when excitotoxic injury occurs in the CNS. They also suggest that the tPA
released from microglia has a critical role in triggering neurodegeneration.
Background
Neuronal cell death occurs as a normal part of develop-
ment in the hippocampus. The loss of neurons is thought
to occur via apoptosis — physiological programmed cell
death [1]. When an injury occurs in the central nervous
system (CNS), however, both necrotic and apoptotic cell
death are observed. One form of injury is elicited by
excessive stimulation, which can be most directly evoked
by agonists of the glutamate receptors, known as excito-
toxins. At elevated concentrations, glutamate, the primary
endogenous excitatory neurotransmitter, can induce both
early necrosis and delayed apoptosis in mixed cortical cul-
tures containing neuronal cells [2,3]. A role for microglial
cells in triggering apoptotic neuronal cell death has been
proposed, as, once activated, they produce ‘cell death’ pro-
teins, such as the cytokines tumor necrosis factor alpha
(TNF-α) and interleukin 1β (IL-1β) [1].
Microglia are cells of the monocyte/macrophage lineage
that populate the brain parenchyma and exist in two major
states: non-activated (ramified, or resting) and activated
(ameboid). The states differ in phagocytic behavior, levels
of expression of macrophage markers, and morphology. As
the CNS matures, the number of ameboid microglia
decreases, possibly because they differentiate to ramified
microglia. Upon neuronal injury, ameboid microglia reap-
pear and are characterized by increased rates of prolifera-
tion and migration, changes in expression of surface
antigens, and changes in morphology [3,4]. However, the
physiological role subsequently undertaken by these acti-
vated microglia has remained controversial.
Some lines of evidence suggest that the activated
microglia are neuroprotective: in mice deficient in TNF
receptors, lipid peroxidation occurs at elevated levels after
intrahippocampal administration of excitotoxins compared
with wild-type mice [5]. This observation suggests that
stimulation of neuronal receptors for TNF through the
action of TNF-α released by activated microglia initiates
antioxidant pathways that protect neurons from oxidative
stress. In addition, microglia were shown in vitro and in
vivo to release neurotrophins, which promote develop-
ment and normal functioning of neurons and glia [6]. On
the other hand, a number of inquiries have suggested that
activated microglia exhibit neurotoxic behaviors as a con-
sequence of injuries elicited by local injections of excito-
toxins [7], autoimmune inflammations [8,9], or ischemia
[10,11]. Secretion of cytokines and neurotoxins [1] by
microglia may help control structural and functional
responses to CNS injury.
Microglia become activated when neuronal cell death is
induced unilaterally in the mouse hippocampus by local
injection of the excitotoxin kainate (a glutamate analog).
In tPA-deficient (tPA–/–) mice [11] treated similarly,
however, hippocampal neurons are resistant to cell death
Addresses: *MSTP Program, University Medical
Center at Stony Brook, Stony Brook, New York
11794-8651, USA. †Department of Pharmacology,
University Medical Center at Stony Brook, Stony
Brook, New York 11794-8651, USA
Correspondence: S.E. Tsirka
E-mail: stella@pharm.som.sunysb.edu
Received: 14 August 1997
Revised: 22 October 1997
Accepted: 24 October 1997
Published: 21 November 1997
Current Biology 1997, 8:19–25
http://biomednet.com/elecref/0960982200800019
© Current Biology Ltd ISSN 0960-9822
Research Paper 19
[12] and the microglial response is attenuated [13]. To
evaluate whether the neuronal susceptibility to death in
wild-type mice is due to factors released by activated
microglia, we designed experiments to inhibit microglial
activation, as described here. To block the activation of
microglia, we used the macrophage/microglial inhibitory
factor (MIF) [14]. MIF is an immunoglobulin G-derived
tripeptide (Thr–Lys–Pro) that retards the activity of cells
of monocytic origin in vivo and in vitro. Furthermore, it
also affects neurodegeneration in a different model of
injury, as administration of MIF delays the axotomy-
induced neuronal degradation of ganglion cells in the
adult rat retina [15]. 
We show here that when MIF is infused into the
hippocampus of wild-type mice that are subsequently
injected with kainate, the microglia fail to become acti-
vated and the neurons exhibit resistance to excitotoxic
death. Our data suggest that under the normal conditions
in which neuronal death is triggered, activated microglial
cells have a neurotoxic role and make significant contribu-
tions to neuronal degeneration. 
Results
Infusion of MIF into the mouse hippocampus inhibits
microglial activation
To examine the contribution of activated microglia to exci-
totoxin-induced neurodegeneration, we examined the
potential of MIF to block excitotoxin-induced microglial
activation in vivo. MIF has been well characterized as an
inhibitor for cells of monocytic origin [15]. Unilateral injec-
tion of the excitotoxin kainate into the hippocampus of
wild-type mice elicits extensive neuronal death over the
pyramidal cell layer CA1–CA3 (see Figure 2 and [7]). After
the injection of the excitotoxin, activation of microglial
cells is observed [7], as determined using immunohisto-
chemistry against the mature macrophage/microglial
marker F4/80 [13]. On the uninjected side, in contrast,
microglia essentially remain in a resting (ramified) state
(Figure 1b).
MIF was infused near the midline at the level of the hip-
pocampal formation in wild-type (C57BL/6J) mice and its
effects on local microglial activation evaluated in the pres-
ence or absence of kainate [7,13]. Seven days after the
onset of MIF delivery into the hippocampus, the degree of
microglial activation was estimated by immunohistochem-
istry. Infusion of MIF alone (with subsequent injection of
saline) had no effect on microglial activation (compare
Figure 1d with Figure 1c). Furthermore, MIF-infused
microglial cells failed to become fully activated after injec-
tion of kainate (compare Figure 1f with Figure 1e). The
microglia in the MIF-infused/kainate-injected side exhib-
ited a less ramified and more oval shape than normal fully
activated microglia (compare Figure 1e with Figure 1a,
respectively). This appearance of the microglial cells
agrees with the morphological findings reported by Thanos
et al. [15] for microglia in MIF-treated rat ganglion cells.
Neuronal degeneration is drastically reduced when
microglial activation is inhibited
We sought next to determine the importance of microglial
activation for excitotoxin-induced neuronal death, using
MIF as described above. Two days after the onset of infu-
sion of MIF or saline, animals were injected unilaterally
with either saline or kainate. After five additional days, the
mice were killed and examined for neuronal survival using
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Figure 1
Microglial activation is inhibited in MIF-infused, kainate-injected wild-
type mice. High magnification (×400) photomicrographs of
representative activated microglia in the CA1 field of stratum radiatum
of C57BL/6J mice are shown. Wild-type mice were infused with saline
(a,b) or MIF (c–f). Two days after the onset of infusions, the mice were
injected unilaterally either with saline (c) or with kainate (KA; a,e).
Seven days post-infusion, mice were killed and coronal sections
through the hippocampus were immunostained with F4/80. (a,c,e)
F4/80+ cells on the side of injection; (b,d,f) control, uninjected side.
Arrows point to microglial cells whose activation appears attenuated,
and the arrowheads point to fully activated microglial cells.
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MIF/KA
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cresyl violet staining. Infusion of the saline control along
the midline, followed by unilateral injection of kainate,
induced extensive neuronal death on the injected side
(Figure 2a) as expected [16,17], whereas the uninjected
side remained unaffected. Infusion of MIF, followed by a
saline injection, did not affect neuronal viability (Figure
2b). In Figure 2c, however, the excitotoxin-induced neu-
ronal death that would have been anticipated from injec-
tion of kainate was blocked virtually completely by the
prior infusion of MIF. Only very limited degeneration
could be observed for the CA3 pyramidal cells located
closest to the CA2–CA3 boundary (Figure 2c). The CA3
hippocampal subfield has the highest affinity kainate
receptors, compared with the other hippocampal regions
[18,19] and is the most sensitive to kainate injury (for
example [7]). Furthermore, since MIF was infused along
the midline (see arrows in Figure 2), a diffusion gradient
of the tripeptide would allow a higher MIF concentra-
tion/neuroprotection over the CA1 neurons, and a sig-
nificantly lower MIF concentration (and therefore
susceptibility to kainate injury) over the CA3 subfield. 
The MIF-mediated protection of hippocampal pyramidal
cells against excitotoxic death demonstrates that inhibi-
tion of microglial activation protects neurons from cell
death (in this experimental model) and suggests as one
possibility that activated microglia might exert their effect
by secreting neurotoxic factors.
Quantitative estimate of migroglial activation by MIF
MIF has been reported to be a specific inhibitor of
microglial activation and, as such, it has been used to
retard axotomy-induced retinal ganglion cell degradation
[15]. To further characterize the effect of MIF on
microglia, we measured the levels of TNF-α, which is
expressed by activated microglia [6]. TNF-α synthesis
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Figure 2
Mice infused with MIF are resistant to kainate-induced neuronal
degeneration. Cresyl-violet-stained coronal sections through the
hippocampus of wild-type mice reveal the neuronal degeneration
induced by kainate (KA). The mice were infused with saline (a), or MIF
in saline for 2 days (b,c). Then saline (b) or kainate (a,c) were injected
unilaterally, the infusion was continued for a further 5 days, and the
mice were analyzed. (a) Section from a wild-type mouse infused with
saline showing extensive kainate-induced neuronal degeneration
(n = 2). (b) Section from a wild-type mouse infused with MIF and
injected with saline demonstrating that MIF has no effect on the status
of neuronal cells (n = 2). (c) Section from a wild-type mouse infused
with MIF, showing resistance to kainate-induced degeneration (n = 2).
The sites of infusion and injection are indicated by arrows. The
uninjected sides remained unaffected. CA1, CA2 and CA3 indicate
the CA1–CA3 pyramidal subfields of the hippocampus.
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Figure 3
MIF inhibits the secretion of TNF-α from LPS-activated microglia. The
amount of TNF-α produced at various time points by activated
microglia was measured in the conditioned medium of mixed cortical
cultures that had been incubated with LPS alone (black bars) and
5 mM MIF (white bars) or 50 mM MIF (gray bars) in addition to LPS
(n = 3), using the Factor-Test-X mouse TNF-α ELISA kit (Genzyme), as
described by the manufacturer. *Not detectable. The p values
associated with the Student’s t-test are: **p < 0.01 and ***p < 0.005. 
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and release are rapidly increased subsequent to microglial
activation. An enzyme-linked immunosorbent assay
(ELISA) was used to determine the concentration of
TNF-α secreted by microglia in mixed cortical cultures, as
a function of added MIF. Microglial activation was stimu-
lated by the addition of lipopolysaccharide (LPS), as
described in Materials and methods. When MIF was
added to the cultures simultaneously with LPS, the levels
of secreted TNF-α were significantly decreased (54–63%)
compared with cultures stimulated with LPS alone (Figure
3). As TNF-α has been shown in several instances to be a
mediator of neuronal cell death [8,20–23], the MIF-medi-
ated attenuated release of TNF-α suggests a plausible
mechanism through which the microglia might induce
neural death.
To confirm that the action of MIF was specific for
microglia and did not have an effect on astrocytes [24], we
performed immunohistochemistry against glial fibrillary
acidic protein (GFAP), a known marker for normal and
reactive astrocytes. No differences were observed in the
numbers or morphology of astrocytes between
saline/kainate and MIF/kainate-treated coronal sections
(data not shown), suggesting that the observations and
measurements obtained in the presence of MIF reflected
changes in microglial activation only.
To test if MIF had any effect on neurons in addition to its
effect on microglia, primary hippocampal neuronal cul-
tures were used. Hippocampal neurons were treated for
3 hours in the absence (Figure 4a) or presence (Figure 4c)
of glutamate (to induce excitotoxic cell death). The fluo-
rescent DNA-binding dye TOPRO was used to detect the
nuclei of dead cells, which stained intensely red (or
yellow, as a result of red–green overlap). The neuronal
marker neuron-specific enolase (NSE), followed by a sec-
ondary antibody coupled to fluorescein isothiocyanate
(FITC), was used to identify the neuronal cells in the
culture (Figure 4, arrow). NSE-positive dead neuronal
cells displayed green cytoplasm and red/yellow nuclei
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MIF does not have a direct effect on neuronal, excitotoxin-mediated,
cell death. Primary hippocampal neuronal cultures were treated with
300 µM glutamate in the presence or absence of 50 µM MIF. Dead
cells are visualized with the fluorescent DNA-binding dye TOPRO
(red); neurons are visualized by immunohistochemistry with anti-NSE
and FITC-conjugated secondary (green) antibodies. Live neurons stain
only green for cytoplasmic NSE (arrows), while dead neurons have
green cytoplasm and bright red nuclei (arrowheads). (a) Untreated
cells; (b) cells treated with 50 µM MIF; (c) cells treated with 300 µM
glutamate, (d) cells treated with 300 µM glutamate in the presence of
50 µM MIF. Scale bars = 20 µm. (e) Graph summarizing the results
(n = 4); black bars indicate 0 µM MIF, white bars 50 µM MIF. The p-
values associated with the Student’s t-test are: *p = 0.58; **p = 0.30,
demonstrating no significant difference in cell viability obtained by the
addition of MIF. The addition of glutamate to the cultures yielded P-
values of: p < 0.01 in the absence or presence of MIF in the cultures. 
(Figure 4, arrowheads). Approximately 25% more dead
neurons were observed in glutamate-treated cultures com-
pared with untreated cultures (Figure 4e, p < 0.01). The
addition of MIF to neurons had no effect on neuronal via-
bility (Figure 4b, p = 0.58). Likewise, when MIF was
added to neurons in the presence of glutamate, the levels
of cell death were similar to those of neurons treated with
glutamate alone (Figures 4c,d, p = 0.30). The results are
summarized in the graph in Figure 4e. We can thus con-
clude that MIF does not have a direct effect on neurons
and presumably exerts its effect via inhibition of micro-
glial activation.
tPA activity is decreased in the presence of MIF
We have previously shown that tPA-deficient mice display
attenuated microglial activation in response to excitotoxic
injury. Furthermore, tPA-deficient neurons are only min-
imally susceptible to excitotoxic cell death [13]. When
recombinant tPA protein is added back by infusion into
the hippocampus of tPA–/– mice, the pyramidal neurons
become susceptible to excitotoxic injury [16], indicating
that tPA is needed acutely at the time of excitotoxic insult
to mediate neuronal death. Finally, microglial cells in
tPA-deficient mice infused with tPA prior to excitotoxin
stimulation exhibited activation comparable to wild-type
activated microglia (data not shown). To correlate the
involvement of secreted microglial tPA with neuronal cell
death directly, we treated wild-type mixed cortical cul-
tures with LPS and MIF (to recapitulate the attenuated
microglial activation observed in tPA–/– microglia), and
measured the amount of tPA activity secreted into the
conditioned medium of these cultures. 
In the medium of cells grown in the absence of MIF, addi-
tion of LPS results in the release of high levels of tPA
activity (Figure 5). When MIF is included in the cultures,
the tPA activity detected in the medium is significantly
decreased (approximately 5–10-fold). MIF has no direct
effect on tPA activity (data not shown). These data indi-
cate that attenuation of microglial activation results in a
decline of tPA activity in the extracellular milieu. They
also suggest that tPA may be one of the cytotoxic factors
contributed by activated microglia that mediates neuronal
cell death.
Discussion
When an injury occurs in the CNS, microglial responses
constitute part of the initial line of defense [3]. Microglial
activation in the context of pathological events in the CNS
leads to the release of tightly regulated and spatially
restricted cytotoxic components [25,26] and, in addition,
the release of neuroprotective factors capable of promot-
ing tissue repair and possible regeneration [1,3,27].
As microglial cells release both kinds of factors, their
role(s) in CNS injuries of various etiologies has been
debated. In favor of a cytotoxic role, microglia have been
shown to produce reactive oxygen radicals [25,28], which
are harmful to neighboring cells. Moreover, TNF-α, a
cytokine secreted by microglia upon activation, inhibits
the re-uptake of glutamate by astrocytes, thereby allowing
higher and potentially toxic concentrations of extracellular
glutamate (the primary excitatory neurotransmitter) to
accumulate [8]. In addition, it has been demonstrated that
upon activation, human microglia synthesize significant
quantities of quinolinic acid, a potent excitotoxin [28].
Furthermore, LPS-activated primary microglial cells are
neurotoxic, whereas resting microglia are not [2]. Finally,
although gerbils subjected to ischemia at physiological
temperatures undergo extensive neuronal death accompa-
nied by the presence of activated microglial cells, gerbils
subjected to ischemia under hypothermic conditions
(which eliminates activation of microglia) exhibit no sig-
nificant neuronal damage [29].
In this report, we have evaluated the role of microglia
using a murine model for neuronal cell death that
involves intrahippocampal, unilateral excitotoxin injec-
tion. MIF was used to block specifically microglial activa-
tion, as no effect of MIF was observed on either neurons
or astrocytes. MIF has been shown to inhibit several
properties of activated macrophages, including injury-
stimulated cell migration, the generation of superoxide
anions, and phagocytosis [14].
Our results demonstrate a neurotoxic role for microglia
after excitotoxic injury. However, microglia are not the
only players in the excitotoxin-induced neurodegenera-
tion pathway. In previous studies using this system, we
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Figure 5
Inhibition of microglial activation by MIF results in decreased secreted
tPA activity. The activity of tPA was measured at various time periods
by the SDS–PAGE/plasminogen zymography assay on media
collected from mixed cortical cultures that had been treated with or
without MIF prior to LPS addition, as described in Materials and
methods. Note the smaller zones of lysis, indicating decreased tPA
activity, in the samples that have been treated with MIF. M indicates
the position of the molecular weight standards, and PA the position of
the two mammalian plasminogen activators, tPA and uPA.
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have shown that tPA and plasminogen are both required
for the induction of neural degeneration. In plasminogen-
deficient mice, we found that microglial activation was
normal, but the neurons were resistant to death [17]. Since
plasminogen is synthesized by neurons exclusively [17],
and tPA is synthesized both by neurons and microglia, it
was possible that microglial activation accompanied neu-
rodegeneration but was not required for it. Taken together
with our present results, we can now conclude that
microglial activation is necessary, but not sufficient, to
trigger neuronal degeneration after excitotoxic insult.
Since, first, the neurodegeneration cascade critically
funnels through the activation of plasminogen, second,
plasminogen is activated solely through the action of tPA
(in the mouse brain), and third, MIF-mediated inhibition
of microglia activation greatly reduces the amount of tPA
released by the microglia, we can hypothesize that
microglial tPA plays a critical role in triggering neuro-
degeneration for which neuronal tPA cannot substitute.
In summary, our data extend previously described obser-
vations that suggest that a localized and cooperative inter-
action may take place between neurons and microglia
after the delivery of excitotoxins which ultimately leads to
neuronal destruction. This communication between the
two cell types results in cell death and the removal of the
affected neurons, whereas neurons that have not been
exposed to the excitotoxin are spared [25].
Materials and methods
Intrahippocampal delivery of MIF and local injection of kainate
Adult C57BL/6J male mice, weighing approximately 25 g, were injected
intraperitoneally with atropine (0.6 mg per kg body weight) and then
deeply anesthetized with 2.5% avertin (0.02 ml per g body weight). They
were placed in a stereotactic apparatus and a micro-osmotic pump
(Alzet) containing saline (for control animals) or 100 µl MIF in saline
(500 µM, Sigma) was placed subcutaneously in the back of the animals.
A brain infusion cannula connected to the pump was positioned at coor-
dinates: bregma –2.5 mm, medial–lateral –0.5 mm and dorsoventral
1.6 mm, to deliver the compound near the midline. The infusion rate was
0.5 µl/h. The pump was allowed to infuse the designated solution for
2 days. The mice were then injected unilaterally into the hippocampus
with 1.5 nmol kainate in 0.3 µl phosphate-buffered saline (PBS) [13].
The coordinates of the injection were: bregma –2.5 mm, medial–lateral
1.7 mm and dorsoventral 1.6 mm. The excitotoxin was delivered over
30 sec. After kainate was delivered, the injection needle remained at the
above coordinates for another 2 min to prevent reflux of fluid. Five days
after the kainate injection, the mice were killed and their brains examined
for neuronal survival and microglial activation. 
Immunohistochemistry
Brain sections of the mice, manipulated as described above, were incu-
bated with antibody to the mature macrophage/microglia-specific
antigen F4/80 (Harlan Bioproducts), at the dilution recommended by
the suppliers (1:10). Biotinylated secondary antibody was used (Vector
Laboratories) and the avidin–biotin–peroxidase complex (ABC reac-
tion) was visualized with diaminobenzidine and hydrogen peroxide
(Vector Laboratories), as described previously [13].
Cell cultures
Mixed cortical cultures were prepared as described [30] with minor
modifications. In brief, cerebral cortices from 1 day old mouse pups were
dissected. The meninges were removed and the tissue was treated with
trypsin (0.25% in Hanks balanced saline solution, HBSS) for 10 min at
37°C. The trypsinization was stopped by addition of serum. The tissue
was mechanically dissociated by trituration. The resulting cell suspen-
sions were then plated in culture media (DMEM supplemented with 10%
fetal bovine serum, and 40 mg/l gentamycin sulfate) onto 12-well poly-L-
lysine-coated tissue culture dishes at a density of one brain per dish.
These cultures were maintained at 37°C in 5% CO2 and the medium
was changed twice weekly. They were allowed to mature for 10–14
days before they were used for the experiments described. 
Primary hippocampal neuronal cultures
Embryonic day 17.5 (E17.5) mice were used to prepare neuronal cul-
tures as previously described [31]. Briefly, pregnant C57/Bl6 mice carry-
ing E17.5-day embryos were killed, and the embryos were removed into
chilled HBSS. The hippocampi were dissected and trypsinized gently
(0.25% trypsin in HBSS) at 37°C for 15 min. Single cell suspensions
were made by trituration and plated onto poly-L-lysine-coated coverslips
at a density of 100,000 cells/cm2 in Neurobasal medium with B27 sup-
plements, 25 µM glutamate, 0.5 mM L-glutamine and 10 mg/l gen-
tamycin sulfate (all from GIBCO). The medium was changed 4 h after
the initial plating and glutamate was removed after 4 days in culture.
Effect of MIF on glutamate-induced neuronal cell death
Primary hippocampal neurons in culture for 8 days were exposed to
300 µM glutamate in the presence or absence of 50 µM MIF for 3 h at
37°C. The cells were washed twice with PBS and fixed for 30 min with
4% paraformaldehyde in PBS at room temperature. The cells were
then exposed to 1 µM TOPRO dye (Molecular Probes) for 10 min at
room temperature to detect dead cells. TOPRO is membrane imperme-
ant and will stain the DNA of cells with compromised membranes.
Neurons were identified by immunohistochemistry using an antibody
against neuronal-specific enolase (NSE, DAKO). Anti-NSE was used at
1:10 and followed by FITC-conjugated goat anti-rabbit secondary anti-
body (Jackson Immunoresearch Laboratories) at 1:100. The cells were
viewed by dual fluorescent confocal microscopy. The relative survival
ratio was determined by counting live and dead neurons. The no
MIF/no glutamate sample was used to standardize the results (n = 4).
PAGE–plasminogen zymography assay
To determine plasminogen activator activity, samples of conditioned
media from cultures treated with LPS in the presence or absence of
MIF were electrophoresed through a 10% sodium dodecyl sulfate
(SDS)–polyacrylamide gel. The gel was washed in 2.5% Triton X-100
to remove the SDS, and in water twice to remove the Triton X-100. The
gel was then placed on a semisolid substrate that contained 25 µg/ml
plasminogen, 1% LMP agarose, 2.5% boiled non-fat Carnation milk
and 0.2% NaN3, and incubated at 37°C overnight. Plasminogen activa-
tor activity is visualized under dark-field illumination.
Activation of microglia in culture
Mixed cortical cultures were prepared in 12-well poly-L-lysine-coated
tissue culture dishes. MIF (Tuftsin fragment 1–3, Sigma) at various con-
centrations, was added to selected cultures 10–14 days after the initial
seeding. At the same time, microglia in these cultures were activated
with LPS (from E. coli strain O26:B6) [32] at a concentration of
100 ng/ml. Aliquots of conditioned media were removed at 1, 2, 4, 8
and 24 h post-LPS addition and assayed for the amount of TNF-α pro-
duced by activated microglia using the Factor-Test-X mouse TNF-α
ELISA kit (Genzyme).
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